Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer

Clinical trial NCT02345265 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02345265
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Fallopian Tube Carcinoma Fallopian Tube Endometrioid Adenocarcinoma Fallopian Tube Serous Adenocarcinoma Ovarian Carcinoma Ovarian High Grade Endometrioid Adenocarcinoma Ovarian High Grade Serous Adenocarcinoma Primary Peritoneal Carcinoma Primary Peritoneal Endometrioid Adenocarcinoma Primary Peritoneal Serous Adenocarcinoma

Start date: 2016-05-23
Primary completion: 2022-07-07
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.